SciSure is a platform for managing laboratory operations end-to-end, built for scientific organizations. It brings together ELN, LIMS, and Health & Safety tools so teams can document experiments, track samples, manage chemical inventory, and maintain compliance workflows that are structured and audit-ready.
By replacing fragmented systems with a single governed platform, SciSure helps organizations improve reproducibility, gain clearer operational visibility, and scale lab operations with less risk.
Learn more
IONOS provides GPU Servers that create a powerful computing environment tailored for handling tasks requiring much greater power than conventional CPU systems can offer. This setup includes high-quality NVIDIA GPUs, such as the H100, H200, and L40s, alongside dedicated AI accelerators like Intel Gaudi, which support extensive parallel processing for resource-intensive applications. With GPU-accelerated instances, the cloud infrastructure is further improved by integrating dedicated graphical processors, allowing virtual machines to perform complex calculations and manage data-heavy operations considerably more swiftly than standard servers. This solution is particularly advantageous in sectors like artificial intelligence, deep learning, and data science, where it is crucial to train models on large datasets or conduct fast inference processes. Additionally, it supports big data analytics, scientific simulations, and visualization tasks requiring significant computational strength, such as 3D rendering and modeling. Consequently, organizations aiming to enhance their processing power for intricate workloads can reap substantial benefits from this sophisticated infrastructure, making it an ideal choice for modern computational demands. Moreover, the flexibility of this service allows businesses to scale their resources according to project requirements, ensuring efficient performance across various applications.
Learn more
Dr.Evidence
Dr.Evidence represents a cutting-edge AI-powered platform designed for landscape intelligence, which seeks to improve efficiency across clinical, regulatory, labeling, safety, market access, and medical affairs domains, thereby enabling life sciences companies to accelerate product introductions and maintain a robust market presence. By integrating teams from diverse locations, therapeutic areas, and departments into a unified scientific knowledge repository, the platform breaks down silos, promotes collaboration, and enhances strategic decision-making processes. Utilizing augmented intelligence that combines human expertise with specialized AI solutions, Dr.Evidence delivers swift insights through effective content summarization and an interactive Q&A feature driven by generative AI technologies. Moreover, it offers powerful scientific search capabilities across an extensive variety of content formats, employing over 25 sophisticated models in large language processing, machine learning, and natural language understanding. Users can quickly assess multiple content sources to obtain a holistic view of the landscape, which ultimately facilitates more informed and timely decisions within their fields. This all-encompassing approach not only optimizes workflows but also leads to significantly improved outcomes in the life sciences sector, enhancing the overall impact on patient care and innovation.
Learn more
Syneos Health
Syneos Health offers comprehensive medical affairs solutions aimed at helping pharmaceutical and biotechnology companies navigate the complex landscape of medical and scientific challenges. Their services encompass developing medical strategies, implementing field medical teams, executing late-phase real-world studies, conducting health economics and outcomes research, and facilitating scientific communication initiatives. By working closely with your organization, Syneos Health seeks to enhance your scientific messaging and value proposition for a diverse range of stakeholders, which ultimately leads to better patient care and more effective product launches. Their all-encompassing approach ensures that the safety, efficacy, and impact of your product on patient outcomes are thoroughly conveyed to the key audiences. This dedication not only increases the recognition of your innovations but also strengthens the relationship between your products and the healthcare community, fostering a collaborative environment for future advancements. Such partnerships are pivotal in driving progress and ensuring that new therapies reach those in need efficiently.
Learn more
